<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">[]. </span>
   <span class="font19">;():â€". </span>
   <span class="font18">patients </span>
   <span class="font17">NCT </span>
   <span class="font16">treatment </span>
   <span class="font16">drugs </span>
   <span class="font16">COVID- </span>
   <span class="font16">SARS-CoV- </span>
   <span class="font16">{border-style </span>
   <span class="font15">clinical </span>
   <span class="font15">viral </span>
   <span class="font15">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font15">drug </span>
   <span class="font15">cardiovascular </span>
   <span class="font14">RNA </span>
   <span class="font14">Cardiovascular </span>
   <span class="font14">effects </span>
   <span class="font14">potential </span>
   <span class="font13">coronavirus </span>
   <span class="font13">effect </span>
   <span class="font13">interval </span>
   <span class="font13">trial </span>
   <span class="font13">virus, </span>
   <span class="font13">Mechanisms </span>
   <span class="font13">prolongation </span>
   <span class="font13">;:. </span>
   <span class="font13">Drug </span>
   <span class="font13">HCQ </span>
   <span class="font13">HIV </span>
   <span class="font13">Interactions </span>
   <span class="font13">Risks </span>
   <span class="font13">inhibitor </span>
   <span class="font13">replication </span>
   <span class="font13">study </span>
   <span class="font13">treating </span>
   <span class="font12">CYPA </span>
   <span class="font12">However, </span>
   <span class="font12">antiviral </span>
   <span class="font12">approved </span>
   <span class="font12">cytochrome </span>
   <span class="font12">disease </span>
   <span class="font12">efficacy </span>
   <span class="font12">fingolimod </span>
   <span class="font12">hydroxychloroquine </span>
   <span class="font12">including </span>
   <span class="font12">metabolized </span>
   <span class="font12">therapeutic </span>
   <span class="font12">trials </span>
   <span class="font12">virus </span>
   <span class="font12">Clin </span>
   <span class="font12">Clinical </span>
   <span class="font12">Medicine, </span>
   <span class="font12">QTc </span>
   <span class="font12">[], </span>
   <span class="font12">case </span>
   <span class="font12">ivermectin </span>
   <span class="font12">polymerase </span>
   <span class="font12">protease </span>
   <span class="font12">px; </span>
   <span class="font12">reported </span>
   <span class="font12">tocilizumab </span>
   <span class="font12">{font-family </span>
   <span class="font12">;:â€". </span>
   <span class="font12">CYPA, </span>
   <span class="font12">CYPC, </span>
   <span class="font12">Dis. </span>
   <span class="font12">Drugs </span>
   <span class="font12">Tocilizumab </span>
   <span class="font12">activity </span>
   <span class="font12">agents </span>
   <span class="font12">anti-SARS-CoV- </span>
   <span class="font12">font-size </span>
   <span class="font12">interactions </span>
   <span class="font12">multiple </span>
   <span class="font12">open-label </span>
   <span class="font12">remdesivir </span>
   <span class="font12">results </span>
   <span class="font12">review </span>
   <span class="font12">rheumatoid </span>
   <span class="font12">used </span>
   <span class="font12">vitro </span>
   <span class="font11">Cheng </span>
   <span class="font11">Hydroxychloroquine </span>
   <span class="font11">Liu </span>
   <span class="font11">RNA-dependent </span>
   <span class="font11">SARS </span>
   <span class="font11">Wang </span>
   <span class="font11">combined </span>
   <span class="font11">current </span>
   <span class="font11">double; </span>
   <span class="font11">effective </span>
   <span class="font11">evaluate </span>
   <span class="font11">favipiravir </span>
   <span class="font11">increase </span>
   <span class="font11">infection </span>
   <span class="font11">inhibitors </span>
   <span class="font11">interaction </span>
   <span class="font11">interferon </span>
   <span class="font11">novel </span>
   <span class="font11">primarily </span>
   <span class="font11">severe </span>
   <span class="font11">significant </span>
   <span class="font11">substrate </span>
   <span class="font11">therapy </span>
   <span class="font11">â€" </span>
   <span class="font11">;():e. </span>
   <span class="font11">COVID-: </span>
   <span class="font11">Coronavirus </span>
   <span class="font11">Department </span>
   <span class="font11">Favipiravir </span>
   <span class="font11">Fingolimod </span>
   <span class="font11">Ivermectin </span>
   <span class="font11">JM, </span>
   <span class="font11">Liver </span>
   <span class="font11">Med </span>
   <span class="font11">Res. </span>
   <span class="font11">Ribavirin </span>
   <span class="font11">active </span>
   <span class="font11">arthritis </span>
   <span class="font11">atazanavir </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cardiac </span>
   <span class="font11">combination </span>
   <span class="font11">compared </span>
   <span class="font11">concentrations </span>
   <span class="font11">copy </span>
   <span class="font11">cytokine </span>
   <span class="font11">immune </span>
   <span class="font11">inhibition </span>
   <span class="font11">metabolism </span>
   <span class="font11">mortality </span>
   <span class="font11">non-randomized </span>
   <span class="font11">pneumonia </span>
   <span class="font11">randomized </span>
   <span class="font11">rapid </span>
   <span class="font11">report </span>
   <span class="font11">reports </span>
   <span class="font11">respiratory </span>
   <span class="font11">ribavirin </span>
   <span class="font11">ritonavir/lopinavir </span>
   <span class="font11">safety </span>
   <span class="font11">showed </span>
   <span class="font11">solid; </span>
   <span class="font11">toxicity </span>
   <span class="font11">use </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">(%) </span>
   <span class="font11">;():. </span>
   <span class="font11">Antimicrob </span>
   <span class="font11">Antivir </span>
   <span class="font11">April </span>
   <span class="font11">China </span>
   <span class="font11">Chloroquine </span>
   <span class="font11">Heart </span>
   <span class="font11">III </span>
   <span class="font11">IL- </span>
   <span class="font11">Int </span>
   <span class="font11">MERS </span>
   <span class="font11">Med. </span>
   <span class="font11">Medical </span>
   <span class="font11">OATPB </span>
   <span class="font11">RSV </span>
   <span class="font11">Ritonavir/lopinavir </span>
   <span class="font11">SARS-CoV-; </span>
   <span class="font11">Trop </span>
   <span class="font11">anti-COVID- </span>
   <span class="font11">atrioventricular </span>
   <span class="font11">bold </span>
   <span class="font11">called </span>
   <span class="font11">cardiotoxicity </span>
   <span class="font11">cause </span>
   <span class="font11">cell </span>
   <span class="font11">cells </span>
   <span class="font11">cells, </span>
   <span class="font11">clinically </span>
   <span class="font11">control </span>
   <span class="font11">courier; </span>
   <span class="font11">dose </span>
   <span class="font11">em; </span>
   <span class="font11">grid.. </span>
   <span class="font11">healthy </span>
   <span class="font11">heart </span>
   <span class="font11">higher </span>
   <span class="font11">inhibit </span>
   <span class="font11">inhibits </span>
   <span class="font11">involved </span>
   <span class="font11">ion </span>
   <span class="font11">lopinavir/ritonavir </span>
   <span class="font11">mechanism </span>
   <span class="font11">number </span>
   <span class="font11">observed </span>
   <span class="font11">ongoing </span>
   <span class="font11">oral </span>
   <span class="font11">potent </span>
   <span class="font11">proteins </span>
   <span class="font11">pt;} </span>
   <span class="font11">receptor </span>
   <span class="font11">regimens </span>
   <span class="font11">ribavirin. </span>
   <span class="font11">risks </span>
   <span class="font11">serum </span>
   <span class="font11">shown </span>
   <span class="font11">site </span>
   <span class="font11">treat </span>
   <span class="font11">ventricular </span>
   <span class="font11">warfarin </span>
  </p>
 </body>
</html>
